Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Stroke

  Free Subscription


Articles published in J Am Coll Cardiol

Retrieve available abstracts of 77 articles:
HTML format
Text format



Single Articles


    March 2017
  1. KONSTANTINIDES SV, Vicaut E, Danays T, Becattini C, et al
    Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism.
    J Am Coll Cardiol. 2017;69:1536-1544.
    PubMed     Text format     Abstract available


    November 2016
  2. GUREWICH V
    Therapeutic Fibrinolysis: How Efficacy and Safety Can Be Improved.
    J Am Coll Cardiol. 2016;68:2099-2106.
    PubMed     Text format     Abstract available


  3. ELGENDY I, Mahmoud A, Bavry A
    TCT-194 Is routine aspiration thrombectomy associated with a higher risk of stroke? A meta-analysis of randomized trials.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  4. LARSON D, Garberich R, Lips D, Burke MN, et al
    TCT-173 Safety of Very Early (< 3hrs) Routine Percutaneous Coronary Intervention after Fibrinolysis in ST-segment Elevation Myocardial Infarction.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  5. KOIFMAN E, Garcia-Garcia HM, Kiramijyan S, Negi S, et al
    TCT-153 Acute Stroke During Primary Percutaneous Coronary Intervention For ST Elevation Myocardial Infarction.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  6. GUTTMANN O, Perera D, Jain A, Mathur A, et al
    TCT-146 Routine Aspiration thrombectomy is associated with increased stroke rates during primary percutaneous coronary intervention for myocardial infarction.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  7. VERGARA R, Valenti R, Migliorini A, Parodi G, et al
    TCT-145 Rheolytic Thrombectomy for Acute Myocardial Infarction Complicated by Cardiogenic Shock.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


    April 2016
  8. EVANS M, Carrero JJ, Szummer K, Akerblom A, et al
    Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Myocardial Infarction Patients With Renal Dysfunction.
    J Am Coll Cardiol. 2016;67:1687-97.
    PubMed     Text format     Abstract available


  9. VADUGANATHAN M, Bhatt DL, Cryer BL, Liu Y, et al
    Proton-Pump Inhibitors Reduce Gastrointestinal Events Regardless of Aspirin Dose in Patients Requiring Dual Antiplatelet Therapy.
    J Am Coll Cardiol. 2016;67:1661-71.
    PubMed     Text format     Abstract available


    March 2016
  10. LOVE BA, Diener HC
    PFO: "Please Figure Out," or Now "Potentially Figured Out?".
    J Am Coll Cardiol. 2016;67:918-20.
    PubMed     Text format    


  11. KENT DM, Dahabreh IJ, Ruthazer R, Furlan AJ, et al
    Device Closure of Patent Foramen Ovale After Stroke: Pooled Analysis of Completed Randomized Trials.
    J Am Coll Cardiol. 2016;67:907-17.
    PubMed     Text format     Abstract available


    February 2016
  12. MARIAN AJ
    Genetic Causality in Complex Traits: The Case of Uric Acid.
    J Am Coll Cardiol. 2016;67:417-9.
    PubMed     Text format    


  13. KEENAN T, Zhao W, Rasheed A, Ho WK, et al
    Causal Assessment of Serum Urate Levels in Cardiometabolic Diseases Through a Mendelian Randomization Study.
    J Am Coll Cardiol. 2016;67:407-16.
    PubMed     Text format     Abstract available


    January 2016
  14. PHILIPPART R, Brunet-Bernard A, Clementy N, Bourguignon T, et al
    CHA2DS2-VASc Score for Predicting Stroke and Thromboembolism in Patients With AF and Biological Valve Prosthesis.
    J Am Coll Cardiol. 2016;67:343-4.
    PubMed     Text format    


  15. BLOOMGARDEN Z, Bansilal S
    A Diabetes-Atrial Fibrillation Conundrum: Does Duration Trump Glycemia?
    J Am Coll Cardiol. 2016;67:248-50.
    PubMed     Text format    


  16. ASHBURNER JM, Go AS, Chang Y, Fang MC, et al
    Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.
    J Am Coll Cardiol. 2016;67:239-47.
    PubMed     Text format     Abstract available


  17. MILLWOOD IY, Bennett DA, Walters RG, Clarke R, et al
    Lipoprotein-Associated Phospholipase A2 Loss-of-Function Variant and Risk of Vascular Diseases in 90,000 Chinese Adults.
    J Am Coll Cardiol. 2016;67:230-1.
    PubMed     Text format    


  18. MASOUDI FA, Calkins H, Kavinsky CJ, Drozda JP Jr, et al
    Reply: Left Atrial Appendage Occlusion Device Societal Overview: The Surgeon's Comment.
    J Am Coll Cardiol. 2016;67:125.
    PubMed     Text format    


  19. EMMERT MY, Salzberg SP
    Left Atrial Appendage Occlusion Device Societal Overview: The Surgeon's Comment.
    J Am Coll Cardiol. 2016;67:124.
    PubMed     Text format    


    November 2015
  20. VAN SLOTEN TT, Sedaghat S, Laurent S, London GM, et al
    Carotid Stiffness Is Associated With Incident Stroke: A Systematic Review and Individual Participant Data Meta-Analysis.
    J Am Coll Cardiol. 2015;66:2116-25.
    PubMed     Text format     Abstract available


  21. PRASAD M, Lerman LO, Lerman A
    Carotid stiffness and cerebrovascular disease: the physiology beyond the anatomy.
    J Am Coll Cardiol. 2015;66:2126-8.
    PubMed     Text format    


  22. HOLMES DR JR
    Reply: Left Atrial Appendage Occlusion Devices Versus Pharmacological Agents for Stroke Prevention in Atrial Fibrillation.
    J Am Coll Cardiol. 2015;66:2058.
    PubMed     Text format    


  23. MESSORI A, Trippoli S
    Left Atrial Appendage Occlusion Devices Versus Pharmacological Agents for Stroke Prevention in Atrial Fibrillation.
    J Am Coll Cardiol. 2015;66:2056-8.
    PubMed     Text format    


  24. WOLFF V, Zinchenko I, Quenardelle V, Rouyer O, et al
    Characteristics and Prognosis of Ischemic Stroke in Young Cannabis Users Compared With Non-Cannabis Users.
    J Am Coll Cardiol. 2015;66:2052-3.
    PubMed     Text format    


    October 2015
  25. CAMM AJ, Savelieva I
    Stroke Risk Stratification in Patients With Atrial Fibrillation: Comme Ci, Comme Ca, Plus Ca Change....
    J Am Coll Cardiol. 2015;66:1860-3.
    PubMed     Text format    


  26. VAN DEN HAM HA, Klungel OH, Singer DE, Leufkens HG, et al
    Comparative Performance of ATRIA, CHADS2, and CHA2DS2-VASc Risk Scores Predicting Stroke in Patients With Atrial Fibrillation: Results From a National Primary Care Database.
    J Am Coll Cardiol. 2015;66:1851-9.
    PubMed     Text format     Abstract available


    September 2015
  27. SAVINO JA 3RD, Halperin JL
    Age, Ethnicity, and Stroke Risk in Patients With Atrial Fibrillation: Another Stitch in the Patchwork.
    J Am Coll Cardiol. 2015;66:1348-9.
    PubMed     Text format    


  28. CHAO TF, Wang KL, Liu CJ, Lin YJ, et al
    Age Threshold for Increased Stroke Risk Among Patients With Atrial Fibrillation: A Nationwide Cohort Study From Taiwan.
    J Am Coll Cardiol. 2015;66:1339-47.
    PubMed     Text format     Abstract available


  29. OPIE LH
    A Proposal to Incorporate Trial Data Into a Hybrid American College of Cardiology/American Heart Association Algorithm for the Allocation of Statin Therapy in Primary Prevention.
    J Am Coll Cardiol. 2015;66:1412-3.
    PubMed     Text format    


  30. BONDE AN, Kamper AL, Olesen JB
    Reply: Clinical Benefit of Warfarin in Dialysis Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2015;66:1311.
    PubMed     Text format    


  31. CHAN PH, Siu CW
    Clinical Benefit of Warfarin in Dialysis Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2015;66:1310-1.
    PubMed     Text format    


  32. SAN ROMAN JA, Vilacosta I, Lopez J, Sarria C, et al
    Critical Questions About Left-Sided Infective Endocarditis.
    J Am Coll Cardiol. 2015;66:1068-76.
    PubMed     Text format     Abstract available


    August 2015
  33. HESS CN, Peterson ED, Peng SA, de Lemos JA, et al
    Use and Outcomes of Triple Therapy Among Older Patients With Acute Myocardial Infarction and Atrial Fibrillation.
    J Am Coll Cardiol. 2015;66:616-27.
    PubMed     Text format     Abstract available


    July 2015
  34. LIP GY, Skjoth F, Rasmussen LH, Nielsen PB, et al
    Net Clinical Benefit for Oral Anticoagulation, Aspirin, or No Therapy in Nonvalvular Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex).
    J Am Coll Cardiol. 2015;66:488-90.
    PubMed     Text format    


  35. WIDIMSKY P, Asil T, Abelson M, Koznar B, et al
    Direct Catheter-Based Thrombectomy for Acute Ischemic Stroke: Outcomes of Consecutive Patients Treated in Interventional Cardiology Centers in Close Cooperation With Neurologists.
    J Am Coll Cardiol. 2015;66:487-8.
    PubMed     Text format    


  36. MARCUS GM, Dewland TA
    Premature Atrial Contractions: A Wolf in Sheep's Clothing?
    J Am Coll Cardiol. 2015;66:242-4.
    PubMed     Text format    


  37. LARSEN BS, Kumarathurai P, Falkenberg J, Nielsen OW, et al
    Excessive Atrial Ectopy and Short Atrial Runs Increase the Risk of Stroke Beyond Incident Atrial Fibrillation.
    J Am Coll Cardiol. 2015;66:232-241.
    PubMed     Text format     Abstract available


  38. BAVARIA JE, Giri J
    Transcatheter Aortic Valve Replacement in Women: Confirming Translational Science or More Confounded Clinical Research?
    J Am Coll Cardiol. 2015;66:229-231.
    PubMed     Text format    


  39. O'CONNOR SA, Morice MC, Gilard M, Leon MB, et al
    Revisiting Sex Equality With Transcatheter Aortic Valve Replacement Outcomes: A Collaborative, Patient-Level Meta-Analysis of 11,310 Patients.
    J Am Coll Cardiol. 2015;66:221-228.
    PubMed     Text format     Abstract available


  40. THOURANI VH, Tsai L, Jensen H
    The Heart and the Head: Neurological Implications of Transcatheter Aortic Valve Replacement.
    J Am Coll Cardiol. 2015;66:218-220.
    PubMed     Text format    


  41. BOSMANS J, Bleiziffer S, Gerckens U, Wenaweser P, et al
    The Incidence and Predictors of Early- and Mid-Term Clinically Relevant Neurological Events After Transcatheter Aortic Valve Replacement in Real-World Patients.
    J Am Coll Cardiol. 2015;66:209-217.
    PubMed     Text format     Abstract available


    June 2015
  42. WAKS JW, Manning WJ
    Left Atrial Appendage Closure to Reduce the Risk of Thromboembolic Complications in Atrial Fibrillation: Pay Now and Possibly Pay Later?
    J Am Coll Cardiol. 2015;65:2624-7.
    PubMed     Text format    


  43. HOLMES DR JR, Doshi SK, Kar S, Price MJ, et al
    Left Atrial Appendage Closure as an Alternative to Warfarin for Stroke Prevention in Atrial Fibrillation: A Patient-Level Meta-Analysis.
    J Am Coll Cardiol. 2015;65:2614-23.
    PubMed     Text format     Abstract available


  44. MASOUDI FA, Calkins H, Kavinsky CJ, Drozda JP Jr, et al
    2015 ACC/HRS/SCAI Left Atrial Appendage Occlusion Device Societal Overview: A Professional Societal Overview from the American College of Cardiology, Heart Rhythm Society, and Society for Cardiovascular Angiography and Interventions.
    J Am Coll Cardiol. 2015 Jun 20. pii: S0735-1097(15)02852.
    PubMed     Text format    


  45. REARDON MJ, Adams DH, Kleiman NS, Yakubov SJ, et al
    2-Year Outcomes in Patients Undergoing Surgical or Self-Expanding Transcatheter Aortic Valve Replacement.
    J Am Coll Cardiol. 2015 Jun 2. pii: S0735-1097(15)02341.
    PubMed     Text format     Abstract available


    May 2015
  46. HIRSH BJ, Copeland-Halperin RS, Halperin JL
    Fibrotic Atrial Cardiomyopathy, Atrial Fibrillation, and Thromboembolism: Mechanistic Links and Clinical Inferences.
    J Am Coll Cardiol. 2015;65:2239-2251.
    PubMed     Text format     Abstract available


  47. WINDLE JR, Windle TA
    Electronic Health Records and the Quest to Achieve the "Triple Aim".
    J Am Coll Cardiol. 2015;65:1973-5.
    PubMed     Text format    


  48. JOYNT KE, Bhatt DL, Schwamm LH, Xian Y, et al
    Lack of impact of electronic health records on quality of care and outcomes for ischemic stroke.
    J Am Coll Cardiol. 2015;65:1964-72.
    PubMed     Text format     Abstract available


  49. MARON BJ, Rowin EJ, Casey SA, Link MS, et al
    Hypertrophic Cardiomyopathy in Adulthood Associated With Low Cardiovascular Mortality With Contemporary Management Strategies.
    J Am Coll Cardiol. 2015;65:1915-28.
    PubMed     Text format     Abstract available


    April 2015
  50. CHAO TF, Liu CJ, Chen SA
    Reply: one more "C" for CHA2DS2-VASc score.
    J Am Coll Cardiol. 2015;65:1603-4.
    PubMed     Text format    


  51. SIU CW
    One more "C" for CHA2DS2-VASc score?
    J Am Coll Cardiol. 2015;65:1602-3.
    PubMed     Text format    


  52. BABER U, Halperin JL
    Variability in low-density lipoprotein cholesterol and cardiovascular risk: should consistency be a new target?
    J Am Coll Cardiol. 2015;65:1549-51.
    PubMed     Text format    


  53. BANGALORE S, Breazna A, DeMicco DA, Wun CC, et al
    Visit-to-Visit Low-Density Lipoprotein Cholesterol Variability and Risk of Cardiovascular Outcomes: Insights From the TNT Trial.
    J Am Coll Cardiol. 2015;65:1539-48.
    PubMed     Text format     Abstract available


  54. LIP GY, Skjoth F, Rasmussen LH, Larsen TB, et al
    Oral anticoagulation, aspirin, or no therapy in patients with nonvalvular AF with 0 or 1 stroke risk factor based on the CHA2DS2-VASc score.
    J Am Coll Cardiol. 2015;65:1385-94.
    PubMed     Text format     Abstract available


  55. PRICE MJ
    The optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: chasing a mirage.
    J Am Coll Cardiol. 2015;65:1311-3.
    PubMed     Text format    


    March 2015
  56. CHATURVEDI S, Sacco RL
    How Recent Data Have Impacted the Treatment of Internal Carotid Artery Stenosis.
    J Am Coll Cardiol. 2015;65:1134-1143.
    PubMed     Text format     Abstract available


  57. KIRTANE AJ, Kelly CR
    Clearing the air on the "smoker's paradox".
    J Am Coll Cardiol. 2015;65:1116-8.
    PubMed     Text format    


  58. ZHANG YJ, Iqbal J, van Klaveren D, Campos CM, et al
    Smoking is associated with adverse clinical outcomes in patients undergoing revascularization with PCI or CABG: the SYNTAX trial at 5-year follow-up.
    J Am Coll Cardiol. 2015;65:1107-15.
    PubMed     Text format     Abstract available


  59. RIDKER PM, Rose L, Cook NR
    A proposal to incorporate trial data into a hybrid ACC/AHA algorithm for the allocation of statin therapy in primary prevention.
    J Am Coll Cardiol. 2015;65:942-8.
    PubMed     Text format     Abstract available


  60. HUISMAN MV
    Patients With Atrial Fibrillation and a CHADS-VASc Score of 1: Are They at Low or High Stroke Risk?
    J Am Coll Cardiol. 2015 Mar 5. pii: S0735-1097(15)00435.
    PubMed     Text format    


    February 2015
  61. CALKINS H
    Data Strengthen to Support Recommending Anticoagulant Therapy for All Atrial Fibrillation Patients With a CHADS-VASc Score >/=1.
    J Am Coll Cardiol. 2015;65:643-644.
    PubMed     Text format    


  62. CHAO TF, Liu CJ, Wang KL, Lin YJ, et al
    Should Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHADS-VASc Score (Beyond Sex) Receive Oral Anticoagulation?
    J Am Coll Cardiol. 2015;65:635-642.
    PubMed     Text format     Abstract available


  63. GIUSTINO G, Baber U, Sartori S, Mehran R, et al
    Duration of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    J Am Coll Cardiol. 2015 Feb 7. pii: S0735-1097(15)00345.
    PubMed     Text format     Abstract available


  64. YANKELSON L, Steinvil A, Adler A, Viskin S, et al
    Reply: life-threatening events during endurance sports: is heat stroke more prevalent than arrhythmic death?
    J Am Coll Cardiol. 2015;65:408-9.
    PubMed     Text format    


  65. SCHERR J, Halle M
    Heat stroke versus cardiac events: a matter of strain duration and climate conditions.
    J Am Coll Cardiol. 2015;65:408.
    PubMed     Text format    


    January 2015
  66. CHEN-SCARABELLI C, Scarabelli TM, Ellenbogen KA, Halperin JL, et al
    Device-Detected Atrial Fibrillation: What to Do With Asymptomatic Patients?
    J Am Coll Cardiol. 2015;65:281-294.
    PubMed     Text format     Abstract available


  67. SINGER DE, Ezekowitz MD
    Adding rigor to stroke risk prediction in atrial fibrillation.
    J Am Coll Cardiol. 2015;65:233-5.
    PubMed     Text format    


  68. FRIBERG L, Skeppholm M, Terent A
    Benefit of Anticoagulation Unlikely in Patients With Atrial Fibrillation and a CHA2DS2-VASc Score of 1.
    J Am Coll Cardiol. 2015;65:225-32.
    PubMed     Text format     Abstract available


    December 2014
  69. OEMRAWSINGH RM, Cheng JM, Garcia-Garcia HM, van Geuns RJ, et al
    Near-infrared spectroscopy predicts cardiovascular outcome in patients with coronary artery disease.
    J Am Coll Cardiol. 2014;64:2510-8.
    PubMed     Text format     Abstract available


  70. BALL T, Wheelan K, McCullough PA
    Chronic anticoagulation in chronic kidney disease.
    J Am Coll Cardiol. 2014;64:2483-5.
    PubMed     Text format    


  71. BONDE AN, Lip GY, Kamper AL, Hansen PR, et al
    Net Clinical Benefit of Antithrombotic Therapy in Patients With Atrial Fibrillation and Chronic Kidney Disease: A Nationwide Observational Cohort Study.
    J Am Coll Cardiol. 2014;64:2471-82.
    PubMed     Text format     Abstract available


  72. HART RG, Halperin JL, Weitz JI
    Vorapaxar, combination antiplatelet therapy, and stroke.
    J Am Coll Cardiol. 2014;64:2327-9.
    PubMed     Text format    


  73. BONACA MP, Scirica BM, Braunwald E, Wiviott SD, et al
    New ischemic stroke and outcomes with vorapaxar versus placebo: results from the TRA 2 degrees P-TIMI 50 trial.
    J Am Coll Cardiol. 2014;64:2318-26.
    PubMed     Text format     Abstract available


  74. BONACA MP, Scirica BM, Braunwald E, Wiviott SD, et al
    Coronary Stent Thrombosis With Vorapaxar Versus Placebo: Results From the TRA 2 degrees P-TIMI 50 Trial.
    J Am Coll Cardiol. 2014;64:2309-17.
    PubMed     Text format     Abstract available


  75. WEBB J, Gerosa G, Lefevre T, Leipsic J, et al
    Multicenter evaluation of a next-generation balloon-expandable transcatheter aortic valve.
    J Am Coll Cardiol. 2014;64:2235-43.
    PubMed     Text format     Abstract available


  76. BORDEN WB, Maddox TM, Tang F, Rumsfeld JS, et al
    Impact of the 2014 Expert Panel Recommendations for Management of High Blood Pressure on Contemporary Cardiovascular Practice: Insights From the NCDR PINNACLE Registry.
    J Am Coll Cardiol. 2014;64:2196-203.
    PubMed     Text format     Abstract available


    November 2014
  77. SPAZIANO M, Francese DP, Leon MB, Genereux P, et al
    Imaging and Functional Testing to Assess Clinical and Subclinical Neurological Events After Transcatheter or Surgical Aortic Valve Replacement: A Comprehensive Review.
    J Am Coll Cardiol. 2014;64:1950-1963.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Stroke is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: